Longitudinal Study on Diaframmatic Ultrasound in FSHD Patients
Longitudinal Interventional Study on Diaphragmatic Ultrasound in Facioscapulohumeral Dystrophy (FSHD) Patients
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
34 participants
Jul 18, 2023
INTERVENTIONAL
Conditions
Summary
The goal of this prospective, longitudinal, single-center study is to describe respiratory function in patients affected by FSHD at baseline and after one year using both diaphragmatic ultrasound and pulmonary function test. The primary questions this study aims to answer are: 1. How does respiratory function assessed by diaphragmatic ultrasound and pulmonary function tests change over 12 months in FSHD patients? 2. How accurate is diaphragmatic ultrasound in detecting respiratory abnormalities in these patients compared to pulmonary function tests? 3. What is the relationship between ultrasound and functional indices, and how do these indices correlate with demographic, clinical, and genetic data? To achieve this, we will enroll a cohort of 34 patients affected by FSHD, and each of them will undergo a comprehensive neurological examination, body plethysmography, measurement of maximal inspiratory pressure (MIP) and maximal espiratory pressure (MEP) and nocturnal oximetry at baseline and after 12 months.
Eligibility
Inclusion Criteria3
- Diagnosis of FSHD, genetically confirmed.
- Adult patients (18 years or older)
- Signature from the patient on the written informed consent document
Exclusion Criteria1
- \- Medical history of neck and mediastinal trauma and/or surgery and/or radiation therapy (e.g. total thyroidectomy, mastectomy) with evidence of phrenic nerve injury.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Ultrasound evaluation of diaphragm thickness, contractility, and excursion in semi-supine and sitting positions.
Routine spirometry, body plethysmography (FRC, TLC), maximal inspiratory/expiratory pressures (MIP, MEP), and nocturnal oximetry.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06078852